Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
TCMD logo TCMD
Upturn stock ratingUpturn stock rating
TCMD logo

Tactile Systems Technology Inc (TCMD)

Upturn stock ratingUpturn stock rating
$12.38
Last Close (24-hour delay)
Profit since last BUY-0.48%
upturn advisory
Consider higher Upturn Star rating
BUY since 6 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: TCMD (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

5 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $13.5

1 Year Target Price $13.5

Analysts Price Target For last 52 week
$13.5 Target price
52w Low $8.61
Current$12.38
52w High $21.1

Analysis of Past Performance

Type Stock
Historic Profit 92.78%
Avg. Invested days 57
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 4.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 275.98M USD
Price to earnings Ratio 19.97
1Y Target Price 13.5
Price to earnings Ratio 19.97
1Y Target Price 13.5
Volume (30-day avg) 5
Beta 0.96
52 Weeks Range 8.61 - 21.10
Updated Date 08/15/2025
52 Weeks Range 8.61 - 21.10
Updated Date 08/15/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.62

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-08-04
When Before Market
Estimate 0.17
Actual 0.14

Profitability

Profit Margin 5.06%
Operating Margin (TTM) 5.18%

Management Effectiveness

Return on Assets (TTM) 4.27%
Return on Equity (TTM) 7.64%

Valuation

Trailing PE 19.97
Forward PE 18.48
Enterprise Value 222165755
Price to Sales(TTM) 0.92
Enterprise Value 222165755
Price to Sales(TTM) 0.92
Enterprise Value to Revenue 0.74
Enterprise Value to EBITDA 7.57
Shares Outstanding 22292100
Shares Floating 19654315
Shares Outstanding 22292100
Shares Floating 19654315
Percent Insiders 2.73
Percent Institutions 101.71

ai summary icon Upturn AI SWOT

Tactile Systems Technology Inc

stock logo

Company Overview

overview logo History and Background

Tactile Systems Technology Inc. was founded in 1993 and is headquartered in Minneapolis, Minnesota. The company focuses on developing and marketing medical devices for the treatment of chronic diseases.

business area logo Core Business Areas

  • Lymphedema and Chronic Venous Insufficiency (CVI): Develops and markets pneumatic compression devices that treat lymphedema and CVI by increasing circulation in the affected area. These are the Flexitouch and ACTitouch Systems.

leadership logo Leadership and Structure

The CEO is Daniel Reuvers. The company is structured with departments like Sales, Marketing, Research and Development, and Operations.

Top Products and Market Share

overview logo Key Offerings

  • Flexitouch System: Pneumatic compression device for treating lymphedema and chronic venous insufficiency. Revenue from this product is a significant portion of the company's total revenue. Competitors include companies offering similar pneumatic compression devices, such as Bio Compression Systems, and Medi GmbH & Co. KG.
  • Market Share: Cannot be accurately determined without access to proprietary market research data. It's a significant player but the overall market is fragmented. Some sources say they have over 50,000 users
  • ACTitouch System: A smaller, more portable pneumatic compression device intended for home use for treating lymphedema and chronic venous insufficiency. This smaller device allows for better ease of use for consumers. Some competitors are compression socks, compression shirts etc.
  • Market Share: Market share for this product is relatively smaller than Flexitouch System but has been growing. Cannot be accurately determined without access to proprietary market research data.

Market Dynamics

industry overview logo Industry Overview

The market for lymphedema and chronic venous insufficiency treatment devices is growing due to an aging population and increased awareness of these conditions.

Positioning

Tactile Systems Technology Inc. is a key player in the pneumatic compression device market. Their competitive advantage lies in their focused product portfolio and specialized technology.

Total Addressable Market (TAM)

The TAM for lymphedema treatment devices is estimated to be in the hundreds of millions of dollars. Tactile Systems Technology Inc. is well-positioned to capture a significant portion of this market. $4B by 2030, the market is fragmented with no one competitor dominating this specific niche.

Upturn SWOT Analysis

Strengths

  • Specialized product portfolio focused on lymphedema and CVI treatment.
  • Established market presence and brand recognition.
  • Strong relationships with healthcare providers and reimbursement specialists.

Weaknesses

  • Reliance on reimbursement approvals for sales growth.
  • Limited product diversification compared to larger medical device companies.
  • Susceptible to changes in healthcare regulations.

Opportunities

  • Expanding product offerings to address related conditions.
  • Increasing market penetration through direct-to-consumer marketing.
  • Acquiring complementary technologies or businesses.

Threats

  • Increased competition from established medical device companies.
  • Changes in reimbursement policies negatively impacting product pricing.
  • Product liability claims.

Competitors and Market Share

competitor logo Key Competitors

  • Bio Compression Systems, Inc
  • Medi GmbH & Co. KG
  • Lympha Press (US stock is unclear, commonly from Israel, LPEM.TA)
  • SIGVARIS

Competitive Landscape

Tactile Systems Technology Inc. competes with a mix of specialized medical device companies and larger, more diversified players. Their strengths lie in their specialized focus and established relationships with healthcare providers, while weaknesses are their dependency on reimbursement approval and a lack of diversification.

Growth Trajectory and Initiatives

Historical Growth: Analysis requires access to historical financial data from official data sources. Unable to provide real-time financial data.

Future Projections: Analysis requires access to up-to-date analyst estimates from official data sources. Unable to provide real-time financial data.

Recent Initiatives: Requires knowledge of their latest actions for example acquisitions, partnerships or mergers. Unable to provide without real-time source data.

Summary

Tactile Systems Technology Inc. focuses on lymphedema and CVI treatment using pneumatic compression devices. It has established relationships with healthcare providers. The company needs to expand its product offerings. Reimbursement approvals and competition are the major concerns.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Industry Reports
  • Market Research Reports

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market data and company specifics may change over time. Consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Tactile Systems Technology Inc

Exchange NASDAQ
Headquaters Minneapolis, MN, United States
IPO Launch date 2016-07-28
CEO, President & Director Ms. Sheri Louise Dodd
Sector Healthcare
Industry Medical Devices
Full time employees 1037
Full time employees 1037

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.